Shi 2005.

Methods	Six‐week, (likely) randomised study.
Participants	In‐patients with depression according to CCMD‐III criteria.
Interventions	Citalopram: 30 participants. Maprotiline: 30 participants. Citalopram dose range: 20 mg/day. Maprotiline dose range: 100‐200 mg/day.
Outcomes	Change in Hamilton Depression Rating Scale (HDRS) score from baseline to endpoint, number of patients who responded to treatment.
Notes	Waiting for translation from Chinese to English (only abstract available in English).